CE认证
皮肤填充剂
Saypha Filler Lidocaine is a viscoelastic implant from Croma-Pharma in Austria, developed to correct moderate to severe nasolabial folds and for lip augmentation. It is suitable for practitioners and must be placed in the mid to deep dermis or submucosa. Its cross-linked hyaluronic acid, obtained from Streptococcus equi bacteria, is supplemented with lidocaine hydrochloride and phosphate-buffered at pH 6.7 to 7.3, giving 2.3% sodium hyaluronate (equivalent to 23 mg/mL) with lidocaine HCl 0.3%, for professional use. Each box contains one pre-filled 1.0 mL syringe with two 27G 1/2 inch needles, three patient record labels and an international implant card.
主要优势： Saypha Filler Lidocaine
- Corrects moderate to severe nasolabial folds and augments the lips
- Cross-linked sodium hyaluronate at 23 mg/mL, of non-animal origin from Streptococcus equi bacteria
- Contains lidocaine hydrochloride 0.3%, which reduces pain and discomfort during injection
- Cross-linked to a mean degree of 0.5 to 1.0% with a typical particle size of approximately 316 micrometres
- BDDE cross-linking agent present at 2 ppm or less
- Steam sterilised in the syringe, which serves as the sterile barrier
- Supplied with two 27G 1/2 inch needles, three patient record labels and an international implant card
- Manufactured by Croma-Pharma in Austria
适应症与专业用途
主要适应症
- Moderate to severe nasolabial folds
- Lip augmentation
专业用途
Saypha Filler Lidocaine is intended for an appropriately trained healthcare professional who is qualified or accredited in accordance with national law, and is not intended to be used by lay persons. It is injected into the mid to deep dermis or submucosa. For healthy adults the maximum total dose of lidocaine hydrochloride should not exceed 300 mg, or 4.5 mg per kg body weight, whichever is less, per session; where other forms of lidocaine are used concurrently, whether topical or injected, the maximum total dose must be considered, and the concomitant use of other local anaesthetics or agents structurally related to amide-type anaesthetics should also be taken into account since systemic toxicity may be additive. Patients should avoid strenuous exercise and exposure to extensive sun or heat in the first 48 hours after injection.
治疗部位
- Nasolabial folds, by mid to deep dermis injection
- Lips, by submucosal injection
适用患者
For adults 18 years of age or older, assessed as suitable by the treating practitioner. It must not be used in those who tend to develop hypertrophic scars, have pigment disorders or a susceptibility to keloid formation, since treatment may trigger these complications. It must not be used in those known to be hypersensitive to hyaluronic acid, gram-positive bacterial proteins, lidocaine hydrochloride or amide-type local anaesthetics, since treatment may trigger allergic reactions of varying severity. It must not be used in pregnant or breast-feeding women, or in individuals younger than 18 years of age.
作用原理： Saypha Filler Lidocaine
Saypha Filler Lidocaine works through cross-linked hyaluronic acid at 23 mg/mL, placed in the mid to deep dermis or the lip submucosa, where it adds volume to correct folds and augment the lip. The gel is cross-linked to a mean degree of 0.5 to 1.0% with a typical particle size of approximately 316 micrometres, and the BDDE cross-linking agent is present at 2 ppm or less. The lidocaine hydrochloride at 0.3% is integrated into the implant in an ancillary role to reduce pain and discomfort caused by the injection. It does not change how the gel behaves in tissue.
为什么选择在 Allpara 订购
Allpara 提供正品、经过验证的 SAYPHA 产品，来自经过严格审核的供应商，具备完整的批次可追溯性和专家支持。我们为诊所和医美专业人士提供CE认证产品、从欧盟仓库快速配送至欧盟各地，以及具有竞争力的专业价格。我们关注的是您患者的安全、满意度和效果，并提供专属售后支持，让您安心无忧。
常见问题
How does Saypha Filler Lidocaine differ from the lidocaine-free Saypha Filler?
The gel concentration is the same at 23 mg/mL. This reference adds lidocaine hydrochloride 0.3% for injection comfort, and is indicated for nasolabial folds and lip augmentation with placement in the mid to deep dermis or submucosa. Where lidocaine is contraindicated, the plain Saypha Filler is the one to order.
How does it differ from Saypha Lips Lidocaine?
Both carry 2.3% sodium hyaluronate with lidocaine 0.3% and share the same registered indication and placement. Saypha Lips Lidocaine additionally documents a cannula option, a 25G x 2 inch or 22G x 2 3/4 inch cannula in place of the needle.
更多产品： Croma-Pharma
水光针
POLYPHIL 产品
查看全部 4
美塑疗法
诊所替代选择
/ 最近浏览
继续浏览
Saypha Filler Lidocaine is a viscoelastic implant from Croma-Pharma in Austria, developed to correct moderate to severe nasolabial folds and for lip augmentation. It is suitable for practitioners and must be placed in the mid to deep dermis or submucosa. Its cross-linked hyaluronic acid, obtained from Streptococcus equi bacteria, is supplemented with lidocaine hydrochloride and phosphate-buffered at pH 6.7 to 7.3, giving 2.3% sodium hyaluronate (equivalent to 23 mg/mL) with lidocaine HCl 0.3%, for professional use. Each box contains one pre-filled 1.0 mL syringe with two 27G 1/2 inch needles, three patient record labels and an international implant card.
主要优势： Saypha Filler Lidocaine
- Corrects moderate to severe nasolabial folds and augments the lips
- Cross-linked sodium hyaluronate at 23 mg/mL, of non-animal origin from Streptococcus equi bacteria
- Contains lidocaine hydrochloride 0.3%, which reduces pain and discomfort during injection
- Cross-linked to a mean degree of 0.5 to 1.0% with a typical particle size of approximately 316 micrometres
- BDDE cross-linking agent present at 2 ppm or less
- Steam sterilised in the syringe, which serves as the sterile barrier
- Supplied with two 27G 1/2 inch needles, three patient record labels and an international implant card
- Manufactured by Croma-Pharma in Austria
适应症与专业用途
主要适应症
- Moderate to severe nasolabial folds
- Lip augmentation
专业用途
Saypha Filler Lidocaine is intended for an appropriately trained healthcare professional who is qualified or accredited in accordance with national law, and is not intended to be used by lay persons. It is injected into the mid to deep dermis or submucosa. For healthy adults the maximum total dose of lidocaine hydrochloride should not exceed 300 mg, or 4.5 mg per kg body weight, whichever is less, per session; where other forms of lidocaine are used concurrently, whether topical or injected, the maximum total dose must be considered, and the concomitant use of other local anaesthetics or agents structurally related to amide-type anaesthetics should also be taken into account since systemic toxicity may be additive. Patients should avoid strenuous exercise and exposure to extensive sun or heat in the first 48 hours after injection.
治疗部位
- Nasolabial folds, by mid to deep dermis injection
- Lips, by submucosal injection
适用患者
For adults 18 years of age or older, assessed as suitable by the treating practitioner. It must not be used in those who tend to develop hypertrophic scars, have pigment disorders or a susceptibility to keloid formation, since treatment may trigger these complications. It must not be used in those known to be hypersensitive to hyaluronic acid, gram-positive bacterial proteins, lidocaine hydrochloride or amide-type local anaesthetics, since treatment may trigger allergic reactions of varying severity. It must not be used in pregnant or breast-feeding women, or in individuals younger than 18 years of age.
作用原理： Saypha Filler Lidocaine
Saypha Filler Lidocaine works through cross-linked hyaluronic acid at 23 mg/mL, placed in the mid to deep dermis or the lip submucosa, where it adds volume to correct folds and augment the lip. The gel is cross-linked to a mean degree of 0.5 to 1.0% with a typical particle size of approximately 316 micrometres, and the BDDE cross-linking agent is present at 2 ppm or less. The lidocaine hydrochloride at 0.3% is integrated into the implant in an ancillary role to reduce pain and discomfort caused by the injection. It does not change how the gel behaves in tissue.
为什么选择在 Allpara 订购
Allpara 提供正品、经过验证的 SAYPHA 产品，具备完整的批次可追溯性、CE认证库存、欧盟范围内快速配送以及专业的售后支持。
常见问题
How does Saypha Filler Lidocaine differ from the lidocaine-free Saypha Filler?
The gel concentration is the same at 23 mg/mL. This reference adds lidocaine hydrochloride 0.3% for injection comfort, and is indicated for nasolabial folds and lip augmentation with placement in the mid to deep dermis or submucosa. Where lidocaine is contraindicated, the plain Saypha Filler is the one to order.
How does it differ from Saypha Lips Lidocaine?
Both carry 2.3% sodium hyaluronate with lidocaine 0.3% and share the same registered indication and placement. Saypha Lips Lidocaine additionally documents a cannula option, a 25G x 2 inch or 22G x 2 3/4 inch cannula in place of the needle.
更多产品： Croma-Pharma
查看制造商 →* 专业用途产品。包装可能因批次或市场而异。完整的使用说明和禁忌症请参阅随附的使用说明书。